|
 |
PRODUCTS |
|
|
FERİMAX |
|
FERİMAX 100 mg/2 mL IM AMPUL |
Therapeutical Group |
Blood and blood forming organs
|
ATC Code |
B03AC02 |
|
Active Substance |
IRON III HYDROXIDE POLYMALTOSE
|
|
Presentation |
Ampoule *Yurtdışı |
|
|
|
|
|
FERİMAX ŞURUP |
Therapeutical Group |
Blood and blood forming organs
|
ATC Code |
B03AB05 |
|
Active Substance |
IRON III HYDROXIDE POLYMALTOSE
|
|
Presentation |
Syrup *Yurtdışı |
|
|
|
|
|
 |
FLATON |
|
FLATON ENTERİK KAPLI DRAJE |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A09AA02 |
|
Active Substance |
HEMICELLULASE
OX-BILE EXTRACT
PANCREATIN
SIMETHICONE
|
|
Presentation |
Enteric dragée |
|
|
|
|
|
 |
FLOPROST |
|
FLOPROST MR 0,4 mg DEĞİŞTİRİLMİŞ SALIMLI SERT KAPSÜL |
Therapeutical Group |
Genito urinary system and sex hormones
|
ATC Code |
G04CA02 |
|
Active Substance |
TAMSULOSIN HCL
|
|
Presentation |
MR hard gelatine capsules |
|
|
|
|
|
 |
FORSEF |
|
FORSEF 0.5 g IM ENJEKTABL FLAKON |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD04 |
|
Active Substance |
CEFTRIAXONE
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
FORSEF 1 g IM ENJEKTABL FLAKON |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD04 |
|
Active Substance |
CEFTRIAXONE
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
FORSEF 0.5 g IV ENJEKTABL FLAKON |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD04 |
|
Active Substance |
CEFTRIAXONE
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
FORSEF 1 g IV ENJEKTABL FLAKON |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD04 |
|
Active Substance |
CEFTRIAXONE
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
 |
FORTİNE |
|
FORTİNE SR 200 mg UZATILMIŞ SALIMLI KAPSÜL |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M01AE09 |
|
Active Substance |
FLURBIPROFEN
|
|
Presentation |
Capsule |
|
|
|
|
|
FORTİNE 100 mg FİLM TABLET |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M01AE09 |
|
Active Substance |
FLURBIPROFEN
|
|
Presentation |
Film coated tablets |
|
|
|
|
|
 |
FUCITEC |
|
FUCİTEC %1 VİSKOZ GÖZ DAMLASI |
Therapeutical Group |
Eye Products
|
ATC Code |
S01AA13 |
|
Active Substance |
FUSIDIC ACID
|
|
Presentation |
5 g Göz Damlası |
|
|
|
|
|
FUCİTEC PLUS KREM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D07CC01 |
|
Active Substance |
FUSIDIC ACID, BETAMETHASONE VALERATE
|
|
Presentation |
Cream |
|
|
|
|
|
FUCİTEC 500 mg FİLM KAPLI TABLET |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01XC01 |
|
Active Substance |
SODIUM FUSIDATE
|
|
Presentation |
Film Tablets |
|
|
|
|
|
FUCİTEC %2 POMAD |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06AX01 |
|
Active Substance |
FUSIDIC ACID
|
|
Presentation |
Pomade |
|
|
|
|
|
FUCİTEC %2 KREM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06AX01 |
|
Active Substance |
FUSIDIC ACID
|
|
Presentation |
Cream |
|
|
|
|
|
 |
|
|
|